289 related articles for article (PubMed ID: 26208877)
1. Cross-cancer profiling of molecular alterations within the human autophagy interaction network.
Lebovitz CB; Robertson AG; Goya R; Jones SJ; Morin RD; Marra MA; Gorski SM
Autophagy; 2015; 11(9):1668-87. PubMed ID: 26208877
[TBL] [Abstract][Full Text] [Related]
2. Here, there be dragons: charting autophagy-related alterations in human tumors.
Lebovitz CB; Bortnik SB; Gorski SM
Clin Cancer Res; 2012 Mar; 18(5):1214-26. PubMed ID: 22253413
[TBL] [Abstract][Full Text] [Related]
3. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract][Full Text] [Related]
4. Network based stratification of major cancers by integrating somatic mutation and gene expression data.
He Z; Zhang J; Yuan X; Liu Z; Liu B; Tuo S; Liu Y
PLoS One; 2017; 12(5):e0177662. PubMed ID: 28520777
[TBL] [Abstract][Full Text] [Related]
5. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.
Maki Y; Fujimoto J; Lang W; Xu L; Behrens C; Wistuba II; Kadara H
Sci Rep; 2015 Sep; 5():13846. PubMed ID: 26343532
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive transcriptional portrait of human cancer cell lines.
Klijn C; Durinck S; Stawiski EW; Haverty PM; Jiang Z; Liu H; Degenhardt J; Mayba O; Gnad F; Liu J; Pau G; Reeder J; Cao Y; Mukhyala K; Selvaraj SK; Yu M; Zynda GJ; Brauer MJ; Wu TD; Gentleman RC; Manning G; Yauch RL; Bourgon R; Stokoe D; Modrusan Z; Neve RM; de Sauvage FJ; Settleman J; Seshagiri S; Zhang Z
Nat Biotechnol; 2015 Mar; 33(3):306-12. PubMed ID: 25485619
[TBL] [Abstract][Full Text] [Related]
10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.
Federico A; Rienzo M; Abbondanza C; Costa V; Ciccodicola A; Casamassimi A
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468258
[TBL] [Abstract][Full Text] [Related]
12. Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.
Bessarabova M; Pustovalova O; Shi W; Serebriyskaya T; Ishkin A; Polyak K; Velculescu VE; Nikolskaya T; Nikolsky Y
Cancer Res; 2011 May; 71(10):3471-81. PubMed ID: 21398405
[TBL] [Abstract][Full Text] [Related]
13. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
[TBL] [Abstract][Full Text] [Related]
14. Association study of genetic variation in the autophagy lysosome pathway genes and risk of eight kinds of cancers.
Tan J; Fu L; Chen H; Guan J; Chen Y; Fang J
Int J Cancer; 2018 Jul; 143(1):80-87. PubMed ID: 29388190
[TBL] [Abstract][Full Text] [Related]
15. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Huang X; Stern DF; Zhao H
Sci Rep; 2016 Feb; 6():20567. PubMed ID: 26837275
[TBL] [Abstract][Full Text] [Related]
17. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
[TBL] [Abstract][Full Text] [Related]
18. Low expression of GABARAPL1 is associated with a poor outcome for patients with hepatocellular carcinoma.
Liu C; Xia Y; Jiang W; Liu Y; Yu L
Oncol Rep; 2014 May; 31(5):2043-8. PubMed ID: 24647565
[TBL] [Abstract][Full Text] [Related]
19. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
